Endress+Hauser Completes Takeover of Analytik Jena

Fuel for thought

Endress+Hauser Completes Takeover of Analytik Jena

01 Apr, 2016

Published over 10 years ago. See the latest and most current information on Fuel for thought.

Swiss measurement and automation engineering specialist Endress+Hauser has completed the takeover of German analytical instrumentation provider Analytik Jena. The remaining minority shares of Analytik Jena were legally transferred to Endress+Hauser on 30 March 2016 following the entry of the transfer resolution in the commercial registry that was previously adopted at the extraordinary general meeting in February. The process will now be finaliSed with the agreed-upon cash payout to the minority shareholders.

In the run up to the completed takeover, as majority shareholder Endress+Hauser owned all but 3.4 percent of the Analytik Jena shares. The demand for the remaining shares was delivered to Analytik Jena in September 2015. This set the final part of the takeover process in motion, during which an independent appraiser fixed the value of the company at 13.68 euros per share.  

Endress+Hauser gained control of publicly-traded Analytik Jena AG in 2013, most recently holding 96.6 percent of the shares. The goal of the acquisition is to eventually be at the side of both companies’ customers from the lab to the process, giving support from product development to production. Analytik Jena employs nearly 1,000 staff worldwide in its core businesses analytical instrumentation and life sciences.

Latest News

PIN 27.3 June/July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
SERS bismuth nanoparticles sensor can spot lead ions in water at high sensitivity
Explore more Arrow
Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow